Michael J. Farrell - 20 Nov 2025 Form 4 Insider Report for RESMED INC (RMD)

Role
Chairman and CEO, Director
Signature
Michael J. Farrell, Chairman and CEO
Issuer symbol
RMD
Transactions as of
20 Nov 2025
Transactions value $
$0
Form type
4
Filing time
24 Nov 2025, 10:42:37 UTC
Previous filing
13 Nov 2025
Next filing
26 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Farrell Michael J. Chairman and CEO, Director RESMED INC., 9001 SPECTRUM CENTER BLVD, SAN DIEGO Michael J. Farrell, Chairman and CEO 21 Nov 2025 0001485164

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Award $0 +13.6K +2.95% $0.00 474K 20 Nov 2025 Direct F1
transaction RMD ResMed Common Stock Tax liability $0 -7.3K -1.54% $0.00 466K 20 Nov 2025 Direct F2
holding RMD ResMed Common Stock 2.09K 20 Nov 2025 Lisette and Michael Farrell Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents performance-based restricted stock units granted on November 16, 2022. The shares were earned on November 20, 2025, when the compensation and leadership development committee certified that the performance metrics were met.
F2 Disposition to issuer for tax withholding on vesting of performance-based restricted stock units granted on November 16, 2022.